Fig. 5. Gal-9 is more potent to eliminate AML with less toxicity towards stromal cells compared to CQ.

A Pictures of CD34⁺ patient-derived AML cells treated with Gal-9 (150, 300 nM) and CQ (20, 50 µM) for 4 days on top of an MS5 monolayer (light microscopy). B Image of MS5 cells only, treated with the indicated concentrations of Gal-9 and CQ for 4 days (light microscopy). C As in (B) but using primary human mesenchymal stem cells (MSC).